Sign in

Simon Pfisterer

@spfisterer.bsky.social
232 followers 386 following 41 posts

Science and technology shape the world. Hope I can help along the path with my research group www.pfistererlab.org and as a founder of www.moncytehealth.com a novel precision medicine company.

PostsRepliesMedia
Simon Pfisterer @spfisterer.bsky.social · 24/09/2026
Today is FH awareness day! We are working hard to improve, diagnosis, risk assessment and precision treatment for people living with FH! @helsinki.fi @magdalenadaccord.bsky.social
000
Simon Pfisterer @spfisterer.bsky.social · 07/09/2026
On my way to the European Lipoprotein Club Meeting in Tutzing!
010
Simon Pfisterer @spfisterer.bsky.social · 29/05/2026
It has been an amazing #EASCongress2026 in Athens. With Poster presentations and our first booth for MONCYTE Health! Great to start new collaborations, meeting friends and colleagues! @eassociety.bsky.social
021
Reposted by Simon Pfisterer
Alexander Bartelt @barteltlab.bsky.social · 25/05/2026
@spfisterer.bsky.social and me having fun at #EAScongress2026!
151
Reposted by Simon Pfisterer
Alexander Bartelt @barteltlab.bsky.social · 24/05/2026
“My LDL is lower than my standards” #EAScongress2026 Today, we held our European Lipoprotein Club Spring Meeting in Athens 🇬🇷. Next, year we will be celebrating our 50th anniversary - save the date Sept 5-8, 2027!
Group pic the organizing committee
1111
Reposted by Simon Pfisterer
Alexander Bartelt @barteltlab.bsky.social · 06/04/2026
(Academic) pedigree is a powerful facilitator of your career. I was the only person in my family with a high school degree, and now I know the impact of having educated parents and an academic (and professional) network.
1134
Simon Pfisterer @spfisterer.bsky.social · 29/03/2026
Greetings from New Orleans! @accintouch.bsky.social scientific sessions!
000
Simon Pfisterer @spfisterer.bsky.social · 24/03/2026
Cycling to work for the first time after a long and cold winter! @helsinki.fi www.moncytehealth.com
041
Simon Pfisterer @spfisterer.bsky.social · 17/03/2026
I am deeply honoured to welcome Prof. Kausik Ray from @imperialcollegeldn.bsky.social as advisor to MONCYTE Health! He is a world leading expert in cardiovascular prevention and lipidology and his work has significantly shaped the understanding and management of lipid disorders and CVD risk. #CVD
011
Simon Pfisterer @spfisterer.bsky.social · 09/02/2026
Sports at below -10°C: Skating, forest walks and running on the sea...
010
Simon Pfisterer @spfisterer.bsky.social · 03/02/2026
EU #FH-Early project aims to redefine familial hypercholesterolemia diagnosis and care. We had a very productive general assembly with important discussions on how to move forward! Thank you organizers! @fpinto1960.bsky.social #FH #cholesterol #CVD @magdalenadaccord.bsky.social
011
Simon Pfisterer @spfisterer.bsky.social · 26/12/2025
Stuck on a bridge in Suvisaaristo! Merry Christmas 🎄
030
Simon Pfisterer @spfisterer.bsky.social · 04/12/2025
Big congratulations to Majharul who defended his PhD thesis last Friday! Amazing job! @helsinki.fi #cholesterol #cvd #PerMed-FH
040
Simon Pfisterer @spfisterer.bsky.social · 18/11/2025
See you at www.slush.org!
020
Simon Pfisterer @spfisterer.bsky.social · 13/11/2025
Back from #AHA2025 scientific sessions! Two poster presentations and discussing the future of cardiovascular disease prevention with colleagues and partners. @ahajournals.bsky.social @eassociety.bsky.social #cholesterol, #CVDprevention.
021
Reposted by Simon Pfisterer
Kristiina Kanerva @kkanerva.bsky.social · 10/11/2025
Adipogenin promotes the development of lipid droplets by binding a dodecameric seipin complex | Science www.science.org/doi/10.1126/...
science.org
Adipogenin promotes the development of lipid droplets by binding a dodecameric seipin complex
The microprotein adipogenin (Adig) is predominantly expressed in adipose tissues. Here, we found that Adig interacts with seipin to form a stable, rigid complex. We present the structure of the seipin...
011
Simon Pfisterer @spfisterer.bsky.social · 31/10/2025
It is a great honour to be part of this study! Congratulations to Daniel Tabet, @fritzroth.bsky.social and the entire team!! This is a huge step forward regarding functional studies of LDLR! www.science.org/doi/10.1126/... @helsinki.fi @eassociety.bsky.social
science.org
The functional landscape of coding variation in the familial hypercholesterolemia gene LDLR
Variants in the familial hypercholesterolemia gene LDLR—the most important genetic driver of cardiovascular disease—can raise circulating low-density lipoprotein (LDL) cholesterol concentrations and i...
051
Reposted by Simon Pfisterer
Holthuis Lab @holthuislab.bsky.social · 25/10/2025
Proud to share a preprint of our paper on how bridge-like lipid transport protein VPS13C senses lysosomal membrane tension in anticipation of membrane lesions to initiate net ER-to-lysosome lipid transfer for efficient lysosomal repair www.biorxiv.org/content/10.1...
biorxiv.org
VPS13C/PARK23 initiates lipid transfer and membrane remodeling for efficient lysosomal repair
Perturbations in lysosome integrity are tightly linked to neurological disorders and ageing, but the underlying pathogenic mechanisms are incompletely understood. Using an unbiased proteomic approach,...
24420
Simon Pfisterer @spfisterer.bsky.social · 20/10/2025
At MONCYTE Health we are looking for a laboratory technician. Are you ready to join a vibrant and exciting team, pushing boundaries in precision medicine? Please apply! More information can be found here: moncytehealth.com/open-positio... The closing date for applications is: 30.11.2025
moncytehealth.com
Open position: on-site laboratory technician - MONCYTE Health
Job description Company Description MONCYTE Health, established in 2024, is an early-stage Finnish health technology company developing a novel solution that integrates cellular diagnostics with robot...
011
Reposted by Simon Pfisterer
Rob Klose @robklose.bsky.social · 17/10/2025
We are recuiting two new Associate Professors here in Oxford Biochemistry. Come join us! Reach out to me if you have any questions. Please repost! tinyurl.com/mr3m7bd3
07797
Reposted by Simon Pfisterer
Holthuis Lab @holthuislab.bsky.social · 17/10/2025
🚨🚨🚨 We are launching the 2nd application round for the Erasmus Mundus Joint Master’s Program MemBioMed, offering cutting-edge training on exploring the complex behavior of cellular membranes & unlocking their therapeutic potential. Students can apply here: life.univ-cotedazur.eu/internationa...
01212
Reposted by Simon Pfisterer
European Atherosclerosis Society @eassociety.bsky.social · 25/09/2025
The EU High-Level Event on cardiovascular health is happening right now at the European Parliament 🇪🇺. Patients, policymakers & experts are coming together to highlight why early screening for FH and Lp(a) must become a European priority.
041
Simon Pfisterer @spfisterer.bsky.social · 18/09/2025
Cycling to work refreshes my brain and improves cardiovascular health! It is also super beautiful if you work in #Helsinki @eassociety.bsky.social #cholesterol #cvd
271
Simon Pfisterer @spfisterer.bsky.social · 11/09/2025
The European Lipoprotein Club Meeting #ELC is special! Great to be back, meeting friends and discussing our latest data from www.moncytehealth.com! @eassociety.bsky.social @barteltlab.bsky.social
151
Reposted by Simon Pfisterer
Guillaume Jacquemet @guijacquemet.bsky.social · 10/09/2025
Come and work with us 5-year position available for a University Researcher in Bioimaging 1.11.2025-31.12.2030 abo.rekrytointi.com/paikat/index...
abo.rekrytointi.com
University Researcher in Bioimaging / Universitetsforskare med inriktning bioimaging, 1.11.2025-31.12.2030
03538
Reposted by Simon Pfisterer
European Atherosclerosis Society @eassociety.bsky.social · 09/09/2025
Join us for a special session in recognition of Familial Hypercholesterolaemia (FH) Awareness Week. This webinar features the recorded session from EAS 2025 in Glasgow, highlighting key insights into FH diagnosis, treatment, and global strategies. Register here: eas.to/WebSep24Reg
021
Reposted by Simon Pfisterer
Gaëlle Letort @gaellel.bsky.social · 04/09/2025
We (with @nicolasdray.bsky.social @zenlabpasteur.bsky.social) are happy to release officially FishFeats, our #napari plugin to streamline 3D smFish/RNA quantification! 🎊 Available here: github.com/gletort/Fish... user documentation: gletort.github.io/FishFeats/
14621
Simon Pfisterer @spfisterer.bsky.social · 02/09/2025
It was great to be there! A big thank you to all of those who made it possible!
000
Simon Pfisterer @spfisterer.bsky.social · 02/09/2025
It was great to present our latest data at #ESC Congress in #Madrid and to catch up with colleagues and friends at one of the most important cardiology conferences! Huge event with great science and clinical data + Madrid is a nice city! @eassociety.bsky.social #moncyte-health #cholesterol #CVD
031
Simon Pfisterer @spfisterer.bsky.social · 25/08/2025
It was very nice recording this podcast and talking about our research at @helsinki.fi and forming the startup company www.moncytehealth.com!
moncytehealth.com
MONCYTE Health
Unique technology and novel data for personalized and optimal treatment of high cholesterol
042
Reposted by Simon Pfisterer
Reese Richardson @reeserichardson.bsky.social · 04/08/2025
Today, our article "The entities enabling scientific fraud at scale are large, resilient, and growing rapidly" is finally published in PNAS. I hope that it proves to be a wake-up-call for the whole scientific community. reeserichardson.blog/2025/08/04/a...
reeserichardson.blog
A do-or-die moment for the scientific enterprise
Reflecting on our paper “The entities enabling scientific fraud at scale are large, resilient, and growing rapidly”
9348207
Reposted by Simon Pfisterer
Rocket Lab @rocketlabcorp.com · 12/08/2025
It’s official, we’ve acquired Geost! Adding space-based missile defense, space protection & space domain awareness sensors to our extensive portfolio of capabilities, securing the technology needed for next-generation defense initiatives & U.S. national security missions - bit.ly/3UmNjRF
74810
Simon Pfisterer @spfisterer.bsky.social · 07/08/2025
Science and innovation are bringing humankind forward. With positive impact on jobs, tax revenue, health and wellbeing. @helsinki.fi and other universities in Finland and around the globe are great examples. Support in them is crucial. Like a seed turning into a great flower!
000
Reposted by Simon Pfisterer
Alexander Bartelt @barteltlab.bsky.social · 04/08/2025
I’m happy that research and development in Germany 🇩🇪 are striving - still so many things to do adopt an open and inclusive culture at German universities.
0104
Reposted by Simon Pfisterer
European Atherosclerosis Society @eassociety.bsky.social · 04/08/2025
As rates of obesity and related metabolic disorders continue to rise globally, the need for an integrated approach to care has never been greater. Join our webinar & learn how this three-stage model offers a holistic strategy for risk reduction, with clear criteria at each step: eas.to/WebOct21Reg
031
Reposted by Simon Pfisterer
@LaBonneLaB @labonnelab.bsky.social · 26/07/2025
Some journals are claiming that you need to pay big $$ for gold open access to comply with NIH's new public access policy. FYI that is total bs. You can comply by depositing the Accepted Manuscript into PubMed Central on the Date of Publication without embargo. Pass it on.
612162
Reposted by Simon Pfisterer
henrietteautzen.bsky.social @henrietteautzen.bsky.social · 03/08/2025
🚨 One week left to apply! I am hiring a fully funded PhD fellow and a postdoc to work on membrane protein structural biology and pharmacology at Univ Copenhagen Come work with a great team and exciting projects in a collaborative environment! 🔗 Links to the ads in comments #CryoEM #AcademicJobs
21912
Reposted by Simon Pfisterer
Technische Universität München @tum.de · 04/08/2025
BioLabs|TUM, a new #biotechnology hub launched by TUM Venture Labs, BioLabs, and Eli Lilly and Company, will open in 2026 in central #Munich. The site will offer lab space, mentoring and networks to early-stage #startups: go.tum.de/297087 #Entrepreneurship 📷BioLabs
go.tum.de
BioLabs|TUM launched to foster start-ups
The TUM Venture Labs, BioLabs and Eli Lilly and Company (Lilly) today launched BioLabs|TUM, a new biotechnology innovation hub.
033
Reposted by Simon Pfisterer
NewAmsterdam Pharma Corporation @newamsterdampharma.bsky.social · 04/08/2025
p-Tau217 is emerging as an important biomarker that can be used to help diagnose and monitor Alzheimer’s disease progression. Levels increase years before memory symptoms appear, making it a helpful indicator for early detection. Get to know this powerful biomarker: bit.ly/47cfrOK
p-Tau217 is an important blood-based biomarker of Alzheimer’s disease
011
Reposted by Simon Pfisterer
Rocket Lab @rocketlabcorp.com · 30/07/2025
We’re ready to make the next era of human spaceflight to Mars possible. Rocket Lab’s Mars Telecommunications Orbiter is designed to deliver real-time, high-bandwidth communications on the Red Planet. 🔗 Learn more: bit.ly/415yjeL
0399
Reposted by Simon Pfisterer
Thierry Galli 🧫🧬🔬🎸🔊 🇪🇺🇫🇷 @tgalli.bsky.social · 24/07/2025
ER_2025 #endoplasmicreticulum #ER #conference Paris October 8-10 2025 Register! itbcrde.inserm.fr/index.php?page…
098
Simon Pfisterer @spfisterer.bsky.social · 24/07/2025
It was great to record an #AtheroTalk podcast and talk about our research and establishing the spinout company www.moncytehealth.com! A big thank you to the #AtheroTalk Team, especially Sanne M. and @azinkh.bsky.social for interviewing me and doing the recording. It has been a very nice experience!
031
Reposted by Simon Pfisterer
European Atherosclerosis Society @eassociety.bsky.social · 23/07/2025
We've launched new expert-led Short Track Courses, designed to equip healthcare professionals with focused, up-to-date knowledge in key areas of lipidology and cardiovascular prevention: eas.to/ShortTracks. All courses are free for EAS members, including National Society and complimentary members.
144
Reposted by Simon Pfisterer
European Atherosclerosis Society @eassociety.bsky.social · 16/07/2025
This autumn, we’re launching a new series of Advanced Courses on Non-classical risk factors for cardiovascular disease. Choose the location closest to you and register now: Sweden: eas.to/NCRFSWEReg Austria: eas.to/NCRFATReg Italy: eas.to/NCRFITReg United Kingdom: eas.to/NCRFUKReg
011
Reposted by Simon Pfisterer
European Atherosclerosis Society @eassociety.bsky.social · 15/07/2025
We didn't forget about our recent AtheroTalk episodes. One of them addresses the question: How do you build confidence and momentum early in your research career? Our guest shares his perspective on navigating the competitive world. 🎧 eas.to/ATHTalkE12S 🎧 eas.to/ATHTalkE12A 🎧 eas.to/ATHTalkE12Y
022
Reposted by Simon Pfisterer
Martina Lorey @martinalorey.bsky.social · 04/07/2025
Check our brief view on why apoB conformation matters: journals.lww.com/co-lipidolog... #apoB #atherosclerosis #LDL #lipoproteins #biochemistry #medsky
journals.lww.com
Beyond cholesterol: linking the conformation of... : Current Opinion in Lipidology
tential of apoB-containing lipoproteins varies substantially both between and within lipoprotein classes. Recent studies using high-resolution cryo-electron microscopy, crosslinking mass spectrometry,...
021
Simon Pfisterer @spfisterer.bsky.social · 25/06/2025
Extremely happy that our work got accepted in #ATVB! We functionally profiled 400 biobank samples, linking cellular lipid uptake, storage and handling to treatment outcomes of statin therapy and residual cardiovascular risk. www.ahajournals.org/doi/10.1161/...
280
Simon Pfisterer @spfisterer.bsky.social · 14/06/2025
Wrapped up the 18th Meeting of the Finnish Atherosclerosis Society — an inspiring and insightful event! Huge thanks to our speakers Florian Kronenberg, Mafalda Bourbon, Jan Boren & Magdalena Daccord for great talks on Lp(a), FH, TRLs, and patient engagement. @eassociety.bsky.social | @helsinki.fi
121
Simon Pfisterer @spfisterer.bsky.social · 14/06/2025
Thank you for highlighting our research!! @jeanwassenaar.bsky.social
010